Trifluoroacetic acid → HCID 71626971, compound
Reaction equation
[C:1]([C:4]1[N:9]=[N:8][C:7]([NH:10][C@@H:11]2[CH2:16][CH2:15][CH2:14][CH2:13][C@@H:12]2[NH:17]C(=O)OC(C)(C)C)=[CH:6][C:5]=1[NH:25][C:26]1[N:31]=[C:30]2[CH2:32][CH2:33][CH2:34][C:29]2=[CH:28][CH:27]=1)(=[O:3])[NH2:2].C(O)(C(F)(F)F)=O>C(Cl)Cl>[NH4+:2].[OH-:3].[NH2:17][C@H:12]1[CH2:13][CH2:14][CH2:15][CH2:16][C@H:11]1[NH:10][C:7]1[N:8]=[N:9][C:4]([C:1]([NH2:2])=[O:3])=[C:5]([NH:25][C:26]2[N:31]=[C:30]3[CH2:32][CH2:33][CH2:34][C:29]3=[CH:28][CH:27]=2)[CH:6]=1Participants
Reactant 2
Product 2
Reagents, catalysts & solvents 1
Procedure
A solution of tert-butyl (1S,2R)-2-(6-carbamoyl-5-(6,7-dihydro-5H-cyclopenta[b]pyridin-2-ylamino)pyridazin-3-ylamino)cyclohexylcarbamate (444 mg, 950 μmol) in CH2Cl2 (5 mL) was treated with TFA (4.08 g, 2.76 mL, 35.8 mmol) and the mixture stirred at room temperature for 18 h. The solvents were evaporated and the residue purified by flash chromatography (spherical silica 20-45 μM, 80 g, Versaflash Supelco) eluting with 0 to 5% of a 9:1 MeOH:NH4OH solution in CH2Cl2, 15 min) to give 6-((1R,2S)-2-aminocyclohexylamino)-4-(6,7-dihydro-5H-cyclopenta[b]pyridin-2-ylamino)pyridazine-3-carboxamide (80 mg, 23%) as an off-white solid. 1H NMR (DMSO-d6) δ: 11.54 (br. s., 1H), 8.35 (br. s., 1H), 7.95 (br. s., 1H), 7.46-7.69 (m, 2H), 6.80 (d, J=7.2 Hz, 1H), 6.69 (d, J=7.6 Hz, 1H), 3.89 (br. s., 1H), 3.12 (br. s., 1H), 2.75-2.98 (m, 4H), 1.96-2.17 (m, 2H), 1.61 (d, J=11.7 Hz, 8H), 1.31 (br. s., 2H); LC-MS 368.3 [M+H]+.
Workup
- customThe solvents were evaporated
- customthe residue purified by flash chromatography (spherical silica 20-45 μM, 80 g, Versaflash Supelco)
- washeluting with 0 to 5% of a 9:1 MeOH
Sources & evidence
- ORD record
- ord-27d64cf739704178bd4da88ce20bdab5
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08901124B2
Reaction notes
Loading…